- Home
- AKRO vs RLJ Comparison
AKRO vs RLJ Comparison
Compare AKRO & RLJ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AKRO
- RLJ
- Stock Information
- Founded
- AKRO 2017
- RLJ 2011
- Country
- AKRO United States
- RLJ United States
- Employees
- AKRO N/A
- RLJ N/A
- Industry
- AKRO Biotechnology: Pharmaceutical Preparations
- RLJ Real Estate Investment Trusts
- Sector
- AKRO Health Care
- RLJ Real Estate
- Exchange
- AKRO Nasdaq
- RLJ Nasdaq
- Market Cap
- AKRO 2.8B
- RLJ 1.5B
- IPO Year
- AKRO 2019
- RLJ 2011
- Fundamental
- Price
- AKRO $37.63
- RLJ $6.97
- Analyst Decision
- AKRO Strong Buy
- RLJ Hold
- Analyst Count
- AKRO 9
- RLJ 8
- Target Price
- AKRO $76.29
- RLJ $10.82
- AVG Volume (30 Days)
- AKRO 1.2M
- RLJ 3.6M
- Earning Date
- AKRO 05-09-2025
- RLJ 05-05-2025
- Dividend Yield
- AKRO N/A
- RLJ 8.65%
- EPS Growth
- AKRO N/A
- RLJ N/A
- EPS
- AKRO N/A
- RLJ 0.27
- Revenue
- AKRO N/A
- RLJ $1,369,899,000.00
- Revenue This Year
- AKRO N/A
- RLJ $2.64
- Revenue Next Year
- AKRO N/A
- RLJ $2.56
- P/E Ratio
- AKRO N/A
- RLJ $25.70
- Revenue Growth
- AKRO N/A
- RLJ 3.31
- 52 Week Low
- AKRO $17.86
- RLJ $6.16
- 52 Week High
- AKRO $58.40
- RLJ $11.48
- Technical
- Relative Strength Index (RSI)
- AKRO 43.61
- RLJ 38.63
- Support Level
- AKRO $36.46
- RLJ $6.72
- Resistance Level
- AKRO $39.13
- RLJ $7.03
- Average True Range (ATR)
- AKRO 3.04
- RLJ 0.47
- MACD
- AKRO 0.06
- RLJ 0.01
- Stochastic Oscillator
- AKRO 57.38
- RLJ 40.66
About AKRO Akero Therapeutics Inc.
Akero Therapeutics Inc is a clinical-stage biotechnology company focused on developing and commercializing transformative treatments for serious metabolic diseases with high unmet medical needs. Its focus is nonalcoholic steatohepatitis (MASH), or NASH, a disease without any approved therapies. The company's product candidate efruxifermin is an FGF21 analog with properties that have the potential to address the core processes underlying NASH pathogenesis.
About RLJ RLJ Lodging Trust of Beneficial Interest $0.01 par value
RLJ Lodging Trust is a real estate investment trust that acquires focused-service and compact full-service hotels. Its portfolio consists of hotels in various states across the United States and the District of Columbia. Its hotels are under the Marriott, Hilton, and Hyatt brand names. These hotels are concentrated in urban areas, dense suburban markets, and business districts within metropolitan areas. Its revenue streams include hotel operations revenue, which is composed of the sale of rooms, food, and beverages, and other property revenue. The company derives the substantial majority of its revenue from the operation of hotels.